115 results
SD
EX-1.01
ABBV
Abbvie Inc
31 May 24
Conflict minerals disclosure
4:05pm
product portfolio that has leadership positions across immunology, oncology, aesthetics, neuroscience and eye care. AbbVie uses its expertise, dedicated
8-K
EX-99.1
ABBV
Abbvie Inc
26 Apr 24
AbbVie Reports First-Quarter 2024 Financial Results
7:43am
financial performance and made a remarkable impact on patients and the communities we serve."
"I want to thank Rick for his exceptional leadership since
424B5
3xsals11uxwaa6cy74s
26 Feb 24
Prospectus supplement for primary offering
6:12am
424B5
om9vp6mxu
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
njsg4o 8rekt5b61
20 Feb 24
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
9:00am
PX14A6G
85v7bbow
4 May 23
Letter to shareholders
8:08am
8-K
EX-99.1
23qmmem9xg3xuaw9p
28 Oct 22
AbbVie Reports Third-Quarter 2022 Financial Results
7:48am
8-K
EX-99.1
bd790
17 Oct 22
Departure of Directors or Certain Officers
9:05am
CORRESP
hrrw6 tjh5
4 Oct 22
Correspondence with SEC
12:00am
UPLOAD
owm5d2
20 Sep 22
Letter from SEC
12:00am
8-K
EX-99.1
3x3e8r7cuewmvciqoi2c
29 Jul 22
AbbVie Reports Second-Quarter 2022 Financial Results
7:49am